Skip to main content
. Author manuscript; available in PMC: 2025 Sep 11.
Published in final edited form as: J Clin Oncol. 2006 Nov 20;24(33):5291–5297. doi: 10.1200/JCO.2006.06.8627

Table 1.

Patient, Tumor, and Treatment Characteristics of the Initial Patient Group, New Patient Group, and All Patients

Initial Group
(n = 54)
New Group
(n = 86)
All Patients
(N = 140)
Characteristic No. % No. % No. % P *
Age, years
 Mean 57.8 60.4 59.4 .24
Sex
 Male 74 84.9 80.7 .12
Tumor site .34
 Oral cavity 11 20 16 19 27 19
 Oropharynx 31 57 39 45 70 50
 Hypopharynx 8 15 22 26 30 22
 Other 4 7 9 11 13 9
Tumor volume, cm2
 Mean 27.5 20.9 23.7 .03
 Not available 5 18
T stage .54
 0–2 27 50 47 55 74 53
 3–4 27 50 39 45 66 47
N stage .07
 0 7 13 21 25 28 20
 1 1 2 6 7 7 5
 2 35 65 51 59 86 61
 3 11 20 8 9 19 14
Stage .02
 I-II 2 4 14 16 16 12.5
 III-IV 52 96 72 84 124 88.5
Hemoglobin, g/dL
 Mean 13.7 13.6 13.6 .8
OPN level, ng/mL
 Mean 490.6 559.3 532.8 .11
 Median 440.3 532.0 496.0
Surgery for primary 35 42 39 .48
Neck dissection 41 40 40 .93
Radiotherapy 93 78 83 .01
Chemotherapy 74 64 68 .20
Mean follow-up, months .003
 All patients 39 27 32 < .0001
 Living patients 63 38 47
Patients with uncontrolled tumor 3 6 8 9 11 8 .42
Patients with relapse 23 43 27 31 50 36 .23
Patients who died 29 54 37 43 66 47 .22

Abbreviation: OPN, osteopontin.

*

P = between initial and new groups.

t test P.

χ2P.